WhichRecall
Class IIIReported 2025-10-01

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-029-01

Recalled by Granules Pharmaceuticals Inc.

Reason for Recall

Failed Impurities/Degradation Specifications:

Advertisement
Recall Number
D-0669-2025
Classification
Class III
Status
Ongoing
Category
drug
Initiated
2025-08-28
Reported
2025-10-01
Distribution
Distributed Nationwide in the USA
Code Info
Lot#: GPC250158A, Exp Date: 06-22-2027
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement